Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer

Nanoscale

Volumn 4, Issue 22, 2012, Pages 7021-7030

  Gao, Xiang ^a,b   Wang, Bilan ^a   Wei, Xiawei ^a   Men, Ke ^a   Zheng, Fengjin ^b   Zhou, Yingfeng ^c   Zheng, Yu ^a   Gou, Maling ^a   Huang, Meijuan ^a   Guo, Gang ^a   Huang, Ning ^b   Qian, Zhiyong ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Department of Pathology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICANCER ACTIVITIES; CANCER CELL APOPTOSIS; DOSE-DEPENDENT MANNER; INTRAVENOUS ADMINISTRATION; MITOCHONDRIAL TRANSMEMBRANE POTENTIALS; MITOGEN ACTIVATED PROTEIN KINASE; MONOMETHOXY POLY(ETHYLENE GLYCOL); OVARIAN CANCER CELLS;

BIOELECTRIC POTENTIALS; CELL DEATH; CELL PROLIFERATION; DISEASES; FLAVONOIDS; HYDROPHOBICITY; MICELLES; PHENOLS; PHOSPHORYLATION; POLYETHYLENE GLYCOLS;

FATTY ACIDS;

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; MACROGOL DERIVATIVE; METHOXY POLY(ETHYLENE GLYCOL CO EPSILON CAPROLACTONE); METHOXY POLY(ETHYLENE GLYCOL-CO-EPSILON-CAPROLACTONE); MITOGEN ACTIVATED PROTEIN KINASE; NANOPARTICLE; POLYESTER; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; QUERCETIN;

ANIMAL; APOPTOSIS; ARTICLE; CHEMISTRY; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; MICELLE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NUDE MOUSE; OVARY TUMOR; PARTICLE SIZE; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; FEMALE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, NUDE; MICELLES; MITOGEN-ACTIVATED PROTEIN KINASES; NANOPARTICLES; OVARIAN NEOPLASMS; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; QUERCETIN; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875793390     PISSN: 20403364     EISSN: 20403372     Source Type: Journal    
DOI: 10.1039/c2nr32181e     Document Type: Article

References (44)

1. American Cancer Society, Cancer Facts & Figures 2011, American Cancer Society, Atlanta, 2011
2. A. Jemal F. Bray M. M. Center J. Ferlay E. Ward D. Forman Global cancer statistics Ca-Cancer J. Clin. 2011 61 2 69 90
3. R. Siegel, M. A. Deepa Naishadham and D. V. M. Ahmedin Jemal, Cancer Statistics, 2012, CA, 2012, pp. 10-29
4. B. T. Hennessy R. L. Coleman M. Markman Ovarian cancer Lancet 2009 374 9698 1371 1382
5. L. Gilbert O. Basso J. Sampalis et al. Assessment of symptomatic women for earlydiagnosis of ovarian cancer: results from the prospective DOvE pilot project Lancet Oncol. 2012 3 13 285 291
6. M. Vanneman G. Dranoff Combining immunotherapy and targeted therapies in cancer treatment Nat. Rev. Cancer 2012 12 237 251
7. R. Dantzer M. W. Meagher C. S. Cleeland Translational approaches to treatment-induced symptoms in cancer patients Nat. Rev. Clin. Oncol. 2012 9 414 426
8. C. J. Lord A. Ashworth The DNA damage response and cancer therapy Nature 2012 481 287 294
9. A. Ślusarz N. S. Shenouda M. S. Sakla et al. Common botanical compounds inhibit the Hedgehog signaling pathway in prostate cancer Cancer Res. 2010 70 3382 3391
10. S. Cheng N. Gao Z. Zhang et al. Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of bax Clin. Cancer Res. 2010 16 5679 5692
11. F. Sahoulia K. Drosopoulos L. Doubravska et al. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts Mol. Cancer Ther. 2007 6 2591 2599
12. M. Comalada D. Camuesco S. Sierra et al. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway Eur. J. Immunol. 2005 35 584 592
13. D. J. L. Jones J. H. Lamb R. D. Verschoyle et al. Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity Br. J. Cancer 2004 91 1213 1219
14. P.-C. Kuo H.-F. Liu J.-I. Chao Survivin and p53 Modulate quercetin-induced cell growth inhibition and apoptosis in human lung Carcinoma cells J. Biol. Chem. 2004 279 55875 55885
15. B. Plaumann M. Fritsche H. Rimpler G. Brandner R. D. Hess Flavonoids activate wild-type p53 Oncogene 1996 13 1605 1614
16. G. Ferrandina G. Almadori N. Maggiano P. Lanza C. Ferlini P. Cattani M. Piantelli G. Scambia F. O. Ranelletti Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors Int. J. Cancer 1998 77 747 754
17. M. Yoshida M. Yamamoto T. Nikaido Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle Cancer Res. 1992 52 6676 6681
18. R. G. Beniston M. S. Campo Quercetin elevates p27Kip1 and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1 Oncogene 2003 22 5504 5514
19. S. Tottey K. J. Waldron S. J. Firbank Protein-folding location can regulate manganese-binding versus copper- or zinc-binding Nature 2008 455 1138 1142
20. C. Voelkel-Johnson TRAIL-mediated signaling in prostate, bladder and renal cancer Nat. Rev. Urol. 2011 8 417 427
21. D. T. Coleman R. Bigelow J. A. Cardelli Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation Mol. Cancer Ther. 2009 8 214 224
22. X. Li Z. Zhang J. Li et al. Diclofenac/biodegradable polymer micelles for ocular applications Nanoscale 2012 4 4667 4673
23. M. C. Parrott J. M. DeSimone Drug delivery: relieving PEGylation Nat. Chem. 2012 4 13 14
24. G. Guo S. Z. Fu L. X. Zhou et al. Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells Nanoscale 2011 3 3825 3832
25. M. L. Gou K. Men J. A. Zhang et al. Efficient inhibition of C-26 colon Carcinoma by VSVMP Gene delivered by biodegradable cationic nanogel derived from polyethyleneimine ACS Nano 2010 4 103-5584 557
26. J.-H. Park L. Gu G. V. Maltzahn et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications Nat. Mater. 2009 8 331 336
27. M. L. Gou K. Men H. S. Shi et al. Curcumin loaded biodegradable polymeric micelle for colon cancer therapy in vitro and in vivo Nanoscale 2011 3 1558 1567
28. M. Gou X. Wei K. Men et al. PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery Curr. Drug Targets 2011 12 1131 1150
29. B. L. Wang X. Gao K. Men Treating acute cystitis with biodegradable micelle-encapsulated quercetin Int. J. Nanomed. 2012 7 2239 2247
30. W. Zhang D. Trachootham J. Liu et al. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia Nat. Cell Biol. 2012 14 276 286
31. H. Jiang N. Song H. Xu et al. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent Cell Res. 2010 20 345 356
32. N. J. Allen M. L. Bennett L. C. Foo et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors Nature 486 410 414
33. Y.-Q. Wei X. Zhao Y. Kariya et al. Induction of apoptosis by quercetin: involvement of heat shock protein Cancer Res. 1994 54 4952 4957
34. Z.-P. Yuan L.-J. Chen L.-Y. Fan et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models Clin. Cancer Res. 2006 12 3193 3199
35. S. Chakraborty S. Stalin N. Das et al., The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat Biomaterials 2012 33 2991 3001
36. G. Scambia F. Ranelletti P. Panici Quercetin and hyperthermia produce a synergistic inhibitory effect on primary human ovarian-cancer cells Int. J. Oncol. 1992 1 3 299 302
37. J. E. Chipuk G. P. McStay A. Bharti et al., Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis Cell 2012 148 988 1000
38. Z. Li J. Jo J.-M. Jia et al., Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization Cell 2010 5 859 871
39. J.-C. Martinou R. J. Youle Mitochondria in apoptosis: bcl-2 family members and mitochondrial dynamics Dev. Cell 2011 1 92 101
40. F. Edlich S. Banerjee M. Suzuki M. M. Cleland et al., Bcl-xL retrotranslocates Bax from the mitochondria into the cytosol Cell 2011 145 104 116
41. I.E. Wertz Saritha Kusam Cynthia Lam et al., Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 Nature 2011 471 110 114
42. M. Hanada J. Feng B. A. Hemmings Structure, regulation and function of PKB/AKT-a major therapeutic target Biochim. Biophys. Acta, Proteins Proteomics 2004 1697 3 16
43. B. T. Hennessy D. L. Smith P. T. Ram Y. Lu G. B. Mills Exploiting the PI3K/AKT pathway for cancer drug discovery Nat. Rev. Drug Discovery 2005 4 988 1004
44. V. Nogueira Y. Park C.-C. Chen et al., Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis Cancer Cell 2008 14 458 470